Clinical Trial

Local Spraying of GM-CSF Via Bronchoscopy in the Treatment of Autoimmune Pulmonary Alveolar Proteinosis

Name: Local Spraying of GM-CSF Via Bronchoscopy in the Treatment of Autoimmune Pulmonary Alveolar Proteinosis — clinical trial record (NCT06989333)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: aPAP and GMCSF

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study aims to explore a new therapeutic approach: the feasibility, safety and preliminary efficacy of directly spraying GM-CSF into the airway through bronchoscopy for the treatment of aPAP.

Trial Details

NCT Number	NCT06989333
Lead Sponsor	Jiuwu Bai
Conditions	Pulmonary Alveolar Proteinosis
Enrollment	10 participants
Start Date	2025-07-01
Primary Completion	2027-06-30 (estimated)
Study Completion	2027-06-30 (estimated)
Updated on ClinicalTrials.gov	2025-05-25